Home/Filings/4/0001062993-22-014508
4//SEC Filing

ERANI ALBERT 4

Accession 0001062993-22-014508

CIK 0001661181other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 7:13 PM ET

Size

14.4 KB

Accession

0001062993-22-014508

Insider Transaction Report

Form 4
Period: 2022-06-06
Erani Dennis
10% Owner
Transactions
  • Sale

    Class A Common Stock

    2022-06-06$5.41/sh100,000$541,00059,348,027 total
  • Sale

    Class A Common Stock

    2022-06-07$5.49/sh50,000$274,50059,298,027 total
  • Sale

    Class A Common Stock

    2022-06-08$5.39/sh20,000$107,80059,278,027 total
Transactions
  • Sale

    Class A Common Stock

    2022-06-06$5.41/sh100,000$541,00059,348,027 total
  • Sale

    Class A Common Stock

    2022-06-08$5.39/sh20,000$107,80059,278,027 total
  • Sale

    Class A Common Stock

    2022-06-07$5.49/sh50,000$274,50059,298,027 total
Transactions
  • Sale

    Class A Common Stock

    2022-06-08$5.39/sh20,000$107,80059,278,027 total
  • Sale

    Class A Common Stock

    2022-06-06$5.41/sh100,000$541,00059,348,027 total
  • Sale

    Class A Common Stock

    2022-06-07$5.49/sh50,000$274,50059,298,027 total
ERANI ALBERT
10% Owner
Transactions
  • Sale

    Class A Common Stock

    2022-06-06$5.41/sh100,000$541,00059,348,027 total
  • Sale

    Class A Common Stock

    2022-06-08$5.39/sh20,000$107,80059,278,027 total
  • Sale

    Class A Common Stock

    2022-06-07$5.49/sh50,000$274,50059,298,027 total
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.55, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  • [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.33 to $5.54, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.34 to $5.49, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  • [F4]Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4.

Issuer

Organogenesis Holdings Inc.

CIK 0001661181

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001074084

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 7:13 PM ET
Size
14.4 KB